Lucid Diligence Brief: Janux Therapeutics and Bristol Myers Squibb collaboration
Lucid Diligence Brief: Janux Therapeutics and Bristol Myers Squibb…
Lucid Diligence Brief: Insilico and Hygtia partner on brain-penetrant NLRP3 inhibitor
Lucid Diligence Brief: Insilico and Hygtia partner on brain-penetrant NLRP3…
Lucid Diligence Brief: Insilico Medicine × Servier oncology collaboration
Lucid Diligence Brief: Insilico Medicine × Servier oncology collaboration…
Lucid Diligence Brief: Zelgen × AbbVie option-to-license on alveltamig
Lucid Diligence Brief: Zelgen × AbbVie option-to-license on alveltamig…
Lucid Diligence Brief: Rectify and Boehringer Ingelheim partnership in CKD
Lucid Diligence Brief: Rectify and Boehringer Ingelheim partnership in CKD…
Lucid Diligence Brief: Chai Discovery $130M Series B
Lucid Diligence Brief: Chai Discovery $130M Series B Professional audiences…
Lucid Diligence Brief: Relation and Novartis atopic disease discovery alliance
Lucid Diligence Brief: Relation and Novartis atopic disease discovery alliance…
Lucid Diligence Brief: SanegeneBio RNAi $110 million Series B
Lucid Diligence Brief: SanegeneBio RNAi $110 million Series B Professional…
Lucid Diligence Brief: Phrontline Biopharma $60m Pre-A+
Lucid Diligence Brief: Phrontline Biopharma $60m Pre-A+ Professional audiences…
Lucid Diligence Brief: Chiesi partners with Aliada (AbbVie) on BBB platform for LSDs
Lucid Diligence Brief: Chiesi partners with Aliada on BBB platform for LSDs…
Lucid Diligence Brief: Iambic raises $100M+ for AI drug discovery
Lucid Diligence Brief: Iambic raises $100M+ for AI drug discovery Professional…
Lucid Diligence Brief: Accipiter Bio $12.7M Seed Funding
Lucid Diligence Brief: Accipiter Bio $12.7M Seed Funding Professional audiences…
